FDA Inspection 1198365 — BioPharma Services, Inc.
The FDA completed an inspection of BioPharma Services, Inc. on October 27, 2022 in North York. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 27, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North York (Canada)
Additional Details
Bioanalytical BA/BE